Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Wirth

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Biomedicines|December 15, 2020
Authentication of Primary Murine Cell Lines by a Microfluidics-Based Lab-On-Chip SystemYingfen Hong, Nikita Singh, Stefanos Bamopoulos, et al.
Cancers|July 29, 2023
NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase InhibitorRamy Ashry, Al-Hassan M Mustafa, Kristin Hausmann, et al.
Journal of Cancer Research and Clinical Oncology|January 15, 2020
Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processesNicole Kiweler, Désirée Wünsch, Matthias Wirth, et al.
International Journal of Cancer|November 2, 2012
Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell deathLaura Conradt, Annika Henrich, Matthias Wirth, et al.
Cell Cycle (Georgetown, Tex.)|March 30, 2012
MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitorsWajana L Labisso, Matthias Wirth, Natasa Stojanovic, et al.
Nucleic Acids Research|August 23, 2014
MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomibMatthias Wirth, Natasa Stojanovic, Jan Christian, et al.
Oncotarget|April 2, 2016
A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptorCarina Lotz-Jenne, Urs Lüthi, Sabine Ackerknecht, et al.
Haematologica|September 22, 2022
Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapyUta M Demel, Matthias Wirth, Schayan Yousefian, et al.
Archives of Toxicology|May 31, 2018
The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cellsNicole Kiweler, Boris Brill, Matthias Wirth, et al.
Molecular Oncology|October 25, 2020
Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYCKatharina Lankes, Zonera Hassan, María Josefina Doffo, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Biomedicines|December 15, 2020
Authentication of Primary Murine Cell Lines by a Microfluidics-Based Lab-On-Chip SystemYingfen Hong, Nikita Singh, Stefanos Bamopoulos, et al.
Cancers|July 29, 2023
NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase InhibitorRamy Ashry, Al-Hassan M Mustafa, Kristin Hausmann, et al.
Journal of Cancer Research and Clinical Oncology|January 15, 2020
Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processesNicole Kiweler, Désirée Wünsch, Matthias Wirth, et al.
International Journal of Cancer|November 2, 2012
Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell deathLaura Conradt, Annika Henrich, Matthias Wirth, et al.
Cell Cycle (Georgetown, Tex.)|March 30, 2012
MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitorsWajana L Labisso, Matthias Wirth, Natasa Stojanovic, et al.
Nucleic Acids Research|August 23, 2014
MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomibMatthias Wirth, Natasa Stojanovic, Jan Christian, et al.
Oncotarget|April 2, 2016
A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptorCarina Lotz-Jenne, Urs Lüthi, Sabine Ackerknecht, et al.
Haematologica|September 22, 2022
Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapyUta M Demel, Matthias Wirth, Schayan Yousefian, et al.
Archives of Toxicology|May 31, 2018
The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cellsNicole Kiweler, Boris Brill, Matthias Wirth, et al.
Molecular Oncology|October 25, 2020
Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYCKatharina Lankes, Zonera Hassan, María Josefina Doffo, et al.
Pageof 7